Analyst Price Targets — STXS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 13, 2026 10:39 am | — | Piper Sandler | $3.50 | $1.92 | TheFly | Stereotaxis price target lowered to $3.50 from $4 at Piper Sandler |
| November 5, 2025 9:23 am | — | UBS | $4.00 | $2.70 | TheFly | Stereotaxis resumed with a Buy at Roth Capital |
| June 23, 2022 7:31 am | Neil Chatterji | B.Riley Financial | $6.00 | $1.94 | Pulse 2.0 | Stereotaxis (STXS) Stock: Why It Increased Over 6% Today |
Latest News for STXS
Stereotaxis, Inc. (STXS) Q2 2026 Earnings Call Transcript
Stereotaxis NYSEAMERICAN: STXS reported second-quarter 2026 revenue of $7.7 million, as growth in sales of its robotic catheter portfolio helped lift recurring revenue to a multiyear high despite lower system revenue and continued supply constraints.
Stereotaxis Inc. (STXS) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.05 per share a year ago.
ST. LOUIS, Mo., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported business updates and financial results for the second quarter ended June 30, 2026.
ST. LOUIS, July 21, 2026 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2026 second quarter on Tuesday, August 11, 2026 at the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for STXS.
U.S. House Trading
No House trades found for STXS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.